| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.024 | 0.6 |